PharmaResources (Shanghai) Co. Ltd. A (301230) — Cash Flow Reinvestment Rate
PharmaResources (Shanghai) Co. Ltd. A (301230) has a Cash Flow Reinvestment Rate of 0.32x as of December 2025, reinvesting CN¥43.51 Million (capex CN¥43.32 Million plus investments CN¥-194.62K) from operating cash flow of CN¥135.51 Million. Check 301230 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmaResources (Shanghai) Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Explore PharmaResources (Shanghai) Co. Ltd. A (301230) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Year-by-year capital reinvestment analysis for PharmaResources (Shanghai) Co. Ltd. A. For live market cap and broader valuation context, see PharmaResources (Shanghai) Co. Ltd. A (301230) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥43.51 Million | CN¥135.51 Million | CN¥43.32 Million | ▼ -85.1% |
| 2024 | 2.15x | CN¥173.84 Million | CN¥80.86 Million | CN¥109.40 Million | ▼ -94.6% |
| 2023 | 39.82x | CN¥830.55 Million | CN¥20.86 Million | CN¥248.27 Million | ▲ +1445.8% |
| 2022 | 2.58x | CN¥255.77 Million | CN¥99.29 Million | CN¥123.97 Million | ▲ +48.5% |
| 2021 | 1.73x | CN¥182.37 Million | CN¥105.12 Million | CN¥92.12 Million | ▲ +83.6% |
| 2020 | 0.94x | CN¥51.46 Million | CN¥54.45 Million | CN¥33.51 Million | — |